person

Chiara U.

Country
Italy
Department
UO Pediatria

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 19 partner sites.

Specializations

Kidney Disease

Investigation of therapeutic strategies to slow renal function decline in patients with Autosomal Dominant Polycystic Kidney Disease.

  • Renal function preservation
  • eGFR trajectory
  • Long‑term disease‑free outcome

Focus includes comparison of disease‑modifying agents in adult cohorts.

Lung Cancer

Evaluation of targeted treatment efficacy in individuals diagnosed with EGFR mutant non‑small cell lung cancer stratified by TP53 status.

  • Progression‑free survival
  • Molecular biomarker impact
  • Personalized therapy selection

Research emphasizes genotype‑guided therapeutic decisions.

Colorectal Oncology

Study of adjuvant therapeutic outcomes for patients with high‑risk stage III colon cancer.

  • Disease‑free survival
  • Adjuvant chemotherapy optimization
  • Risk‑adjusted treatment pathways

Efforts aim to refine postoperative management protocols.

Breast Cancer

Implementation of biomarker‑driven approaches for HR‑positive, HER2‑negative metastatic breast cancer.

  • Second‑line treatment intensity
  • Liquid biopsy integration
  • Therapeutic personalization

Projects target improved outcomes through molecular monitoring.

Ovarian Cancer

Exploration of maintenance strategies in patients with recurrent ovarian cancer lacking germline or somatic BRCA alterations.

  • Biomarker‑guided maintenance therapy
  • Platinum‑sensitivity assessment
  • Prognostic molecular profiling

Research focuses on extending remission periods without BRCA‑targeted agents.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.